nodes	percent_of_prediction	percent_of_DWPC	metapath
Drospirenone—AR—hematologic cancer	0.21	1	CbGaD
Drospirenone—NR3C2—Betamethasone—hematologic cancer	0.0515	0.153	CbGbCtD
Drospirenone—NR3C2—Prednisolone—hematologic cancer	0.0508	0.151	CbGbCtD
Drospirenone—PTGS2—Lenalidomide—hematologic cancer	0.0378	0.112	CbGbCtD
Drospirenone—PGR—Betamethasone—hematologic cancer	0.0333	0.099	CbGbCtD
Drospirenone—NR3C2—Dexamethasone—hematologic cancer	0.03	0.0891	CbGbCtD
Drospirenone—PTGS2—Thalidomide—hematologic cancer	0.0202	0.06	CbGbCtD
Drospirenone—PGR—Dexamethasone—hematologic cancer	0.0193	0.0576	CbGbCtD
Drospirenone—BCHE—Triamcinolone—hematologic cancer	0.0182	0.0541	CbGbCtD
Drospirenone—Potassium Canrenoate—Prednisone—hematologic cancer	0.0178	0.0659	CrCrCtD
Drospirenone—Potassium Canrenoate—Prednisolone—hematologic cancer	0.0174	0.0643	CrCrCtD
Drospirenone—Flurandrenolide—Betamethasone—hematologic cancer	0.0151	0.0558	CrCrCtD
Drospirenone—Flurandrenolide—Dexamethasone—hematologic cancer	0.0151	0.0558	CrCrCtD
Drospirenone—Medrysone—Prednisolone—hematologic cancer	0.0147	0.0543	CrCrCtD
Drospirenone—PTGS2—Triamcinolone—hematologic cancer	0.014	0.0416	CbGbCtD
Drospirenone—BCHE—Irinotecan—hematologic cancer	0.0138	0.041	CbGbCtD
Drospirenone—Flurandrenolide—Prednisolone—hematologic cancer	0.0136	0.0505	CrCrCtD
Drospirenone—Testolactone—Dexamethasone—hematologic cancer	0.0132	0.0491	CrCrCtD
Drospirenone—Testolactone—Betamethasone—hematologic cancer	0.0132	0.0491	CrCrCtD
Drospirenone—Testolactone—Triamcinolone—hematologic cancer	0.0129	0.0479	CrCrCtD
Drospirenone—Cortisone acetate—Prednisone—hematologic cancer	0.0127	0.0469	CrCrCtD
Drospirenone—Cortisone acetate—Prednisolone—hematologic cancer	0.0124	0.0458	CrCrCtD
Drospirenone—Testolactone—Prednisone—hematologic cancer	0.0123	0.0455	CrCrCtD
Drospirenone—PTGS2—Betamethasone—hematologic cancer	0.012	0.0357	CbGbCtD
Drospirenone—Testolactone—Prednisolone—hematologic cancer	0.012	0.0444	CrCrCtD
Drospirenone—BCHE—Cisplatin—hematologic cancer	0.0112	0.0334	CbGbCtD
Drospirenone—Progesterone—Prednisolone—hematologic cancer	0.0107	0.0398	CrCrCtD
Drospirenone—Methyltestosterone—Prednisone—hematologic cancer	0.0107	0.0397	CrCrCtD
Drospirenone—Methyltestosterone—Prednisolone—hematologic cancer	0.0105	0.0388	CrCrCtD
Drospirenone—Hydrocortisone—Dexamethasone—hematologic cancer	0.00967	0.0358	CrCrCtD
Drospirenone—Hydrocortisone—Betamethasone—hematologic cancer	0.00967	0.0358	CrCrCtD
Drospirenone—Hydrocortisone—Triamcinolone—hematologic cancer	0.00945	0.035	CrCrCtD
Drospirenone—Testosterone—Prednisolone—hematologic cancer	0.00932	0.0345	CrCrCtD
Drospirenone—PGR—ovarian follicle—hematologic cancer	0.00929	0.315	CbGeAlD
Drospirenone—Hydrocortisone—Prednisone—hematologic cancer	0.00897	0.0332	CrCrCtD
Drospirenone—Hydrocortisone—Prednisolone—hematologic cancer	0.00876	0.0324	CrCrCtD
Drospirenone—PTGS2—Cisplatin—hematologic cancer	0.00863	0.0257	CbGbCtD
Drospirenone—PTGS2—Etoposide—hematologic cancer	0.00848	0.0253	CbGbCtD
Drospirenone—PTGS2—Dexamethasone—hematologic cancer	0.00698	0.0208	CbGbCtD
Drospirenone—PTGS2—ovarian follicle—hematologic cancer	0.00464	0.157	CbGeAlD
Drospirenone—NR3C2—hematopoietic system—hematologic cancer	0.00121	0.0409	CbGeAlD
Drospirenone—PGR—hematopoietic system—hematologic cancer	0.00112	0.038	CbGeAlD
Drospirenone—AR—hematopoietic system—hematologic cancer	0.000894	0.0303	CbGeAlD
Drospirenone—NR3C2—blood—hematologic cancer	0.000799	0.0271	CbGeAlD
Drospirenone—PGR—blood—hematologic cancer	0.000743	0.0252	CbGeAlD
Drospirenone—BCHE—hematopoietic system—hematologic cancer	0.000727	0.0246	CbGeAlD
Drospirenone—NR3C2—lung—hematologic cancer	0.000701	0.0238	CbGeAlD
Drospirenone—AR—gonad—hematologic cancer	0.000679	0.023	CbGeAlD
Drospirenone—NR3C2—testis—hematologic cancer	0.000661	0.0224	CbGeAlD
Drospirenone—PGR—lung—hematologic cancer	0.000651	0.0221	CbGeAlD
Drospirenone—PGR—testis—hematologic cancer	0.000615	0.0208	CbGeAlD
Drospirenone—AR—blood—hematologic cancer	0.000592	0.0201	CbGeAlD
Drospirenone—PTGS2—hematopoietic system—hematologic cancer	0.00056	0.019	CbGeAlD
Drospirenone—AR—lung—hematologic cancer	0.000519	0.0176	CbGeAlD
Drospirenone—AR—testis—hematologic cancer	0.00049	0.0166	CbGeAlD
Drospirenone—BCHE—blood—hematologic cancer	0.000482	0.0163	CbGeAlD
Drospirenone—NR3C2—lymph node—hematologic cancer	0.000479	0.0162	CbGeAlD
Drospirenone—BCHE—bone marrow—hematologic cancer	0.000466	0.0158	CbGeAlD
Drospirenone—PGR—lymph node—hematologic cancer	0.000446	0.0151	CbGeAlD
Drospirenone—BCHE—lung—hematologic cancer	0.000422	0.0143	CbGeAlD
Drospirenone—BCHE—testis—hematologic cancer	0.000398	0.0135	CbGeAlD
Drospirenone—PTGS2—blood—hematologic cancer	0.000371	0.0126	CbGeAlD
Drospirenone—PTGS2—bone marrow—hematologic cancer	0.000359	0.0122	CbGeAlD
Drospirenone—AR—lymph node—hematologic cancer	0.000355	0.012	CbGeAlD
Drospirenone—PTGS2—lung—hematologic cancer	0.000325	0.011	CbGeAlD
Drospirenone—BCHE—lymph node—hematologic cancer	0.000289	0.00979	CbGeAlD
Drospirenone—PTGS2—Fluocinonide—Dexamethasone—hematologic cancer	0.000274	0.209	CbGdCrCtD
Drospirenone—PTGS2—Fluocinonide—Betamethasone—hematologic cancer	0.000274	0.209	CbGdCrCtD
Drospirenone—PTGS2—Fluocinonide—Triamcinolone—hematologic cancer	0.000267	0.205	CbGdCrCtD
Drospirenone—PTGS2—lymph node—hematologic cancer	0.000222	0.00754	CbGeAlD
Drospirenone—Testosterone Propionate—UGT1A1—hematologic cancer	0.000196	0.0857	CrCbGaD
Drospirenone—PTGS2—Fluticasone Propionate—Dexamethasone—hematologic cancer	0.000165	0.126	CbGdCrCtD
Drospirenone—PTGS2—Fluticasone Propionate—Betamethasone—hematologic cancer	0.000165	0.126	CbGdCrCtD
Drospirenone—PTGS2—Fluticasone Propionate—Triamcinolone—hematologic cancer	0.000161	0.124	CbGdCrCtD
Drospirenone—Medrysone—NR3C1—hematologic cancer	0.000146	0.0641	CrCbGaD
Drospirenone—Flurandrenolide—NR3C1—hematologic cancer	0.000141	0.0618	CrCbGaD
Drospirenone—Testosterone Propionate—AR—hematologic cancer	0.00014	0.0613	CrCbGaD
Drospirenone—Cortisone acetate—NR3C1—hematologic cancer	0.000134	0.0588	CrCbGaD
Drospirenone—Acute coronary syndrome—Ifosfamide—hematologic cancer	0.00013	0.00137	CcSEcCtD
Drospirenone—Megestrol acetate—NR3C1—hematologic cancer	0.000129	0.0567	CrCbGaD
Drospirenone—Myocardial infarction—Ifosfamide—hematologic cancer	0.000129	0.00136	CcSEcCtD
Drospirenone—Unspecified disorder of skin and subcutaneous tissue—Nilotinib—hematologic cancer	0.000128	0.00136	CcSEcCtD
Drospirenone—Nausea—Lomustine—hematologic cancer	0.000128	0.00136	CcSEcCtD
Drospirenone—Depression—Vincristine—hematologic cancer	0.000128	0.00135	CcSEcCtD
Drospirenone—Unspecified disorder of skin and subcutaneous tissue—Imatinib—hematologic cancer	0.000128	0.00135	CcSEcCtD
Drospirenone—Acute coronary syndrome—Vincristine—hematologic cancer	0.000126	0.00134	CcSEcCtD
Drospirenone—Angiopathy—Bortezomib—hematologic cancer	0.000126	0.00134	CcSEcCtD
Drospirenone—Mood swings—Prednisolone—hematologic cancer	0.000126	0.00133	CcSEcCtD
Drospirenone—Myocardial infarction—Vincristine—hematologic cancer	0.000126	0.00133	CcSEcCtD
Drospirenone—Unspecified disorder of skin and subcutaneous tissue—Cladribine—hematologic cancer	0.000126	0.00133	CcSEcCtD
Drospirenone—Angiopathy—Vinorelbine—hematologic cancer	0.000123	0.0013	CcSEcCtD
Drospirenone—Acute coronary syndrome—Irinotecan—hematologic cancer	0.000123	0.0013	CcSEcCtD
Drospirenone—Acute coronary syndrome—Mitoxantrone—hematologic cancer	0.000123	0.0013	CcSEcCtD
Drospirenone—Nausea—Mechlorethamine—hematologic cancer	0.000123	0.0013	CcSEcCtD
Drospirenone—Myocardial infarction—Mitoxantrone—hematologic cancer	0.000122	0.00129	CcSEcCtD
Drospirenone—Myocardial infarction—Irinotecan—hematologic cancer	0.000122	0.00129	CcSEcCtD
Drospirenone—Mental disorder—Bortezomib—hematologic cancer	0.000122	0.00129	CcSEcCtD
Drospirenone—Gastrointestinal disorder—Busulfan—hematologic cancer	0.000122	0.00129	CcSEcCtD
Drospirenone—Nervous system disorder—Nilotinib—hematologic cancer	0.000122	0.00129	CcSEcCtD
Drospirenone—Haemoglobin—Carmustine—hematologic cancer	0.000121	0.00128	CcSEcCtD
Drospirenone—Nervous system disorder—Imatinib—hematologic cancer	0.000121	0.00128	CcSEcCtD
Drospirenone—Haemorrhage—Carmustine—hematologic cancer	0.000121	0.00128	CcSEcCtD
Drospirenone—Skin disorder—Nilotinib—hematologic cancer	0.00012	0.00127	CcSEcCtD
Drospirenone—Affect lability—Triamcinolone—hematologic cancer	0.00012	0.00127	CcSEcCtD
Drospirenone—Haemoglobin—Alitretinoin—hematologic cancer	0.00012	0.00127	CcSEcCtD
Drospirenone—Acute coronary syndrome—Gemcitabine—hematologic cancer	0.00012	0.00127	CcSEcCtD
Drospirenone—Skin disorder—Imatinib—hematologic cancer	0.00012	0.00127	CcSEcCtD
Drospirenone—Haemorrhage—Alitretinoin—hematologic cancer	0.000119	0.00126	CcSEcCtD
Drospirenone—Breast pain—Epirubicin—hematologic cancer	0.000119	0.00126	CcSEcCtD
Drospirenone—Myocardial infarction—Gemcitabine—hematologic cancer	0.000119	0.00126	CcSEcCtD
Drospirenone—Nervous system disorder—Cladribine—hematologic cancer	0.000119	0.00126	CcSEcCtD
Drospirenone—Erythema multiforme—Thalidomide—hematologic cancer	0.000119	0.00126	CcSEcCtD
Drospirenone—Haemoglobin—Ifosfamide—hematologic cancer	0.000119	0.00126	CcSEcCtD
Drospirenone—Spironolactone—AR—hematologic cancer	0.000119	0.052	CrCbGaD
Drospirenone—Haemorrhage—Ifosfamide—hematologic cancer	0.000118	0.00125	CcSEcCtD
Drospirenone—Angiopathy—Thiotepa—hematologic cancer	0.000118	0.00125	CcSEcCtD
Drospirenone—Skin disorder—Cladribine—hematologic cancer	0.000118	0.00125	CcSEcCtD
Drospirenone—Gastrointestinal disorder—Bexarotene—hematologic cancer	0.000116	0.00123	CcSEcCtD
Drospirenone—Gastrointestinal disorder—Dasatinib—hematologic cancer	0.000116	0.00123	CcSEcCtD
Drospirenone—Mood swings—Triamcinolone—hematologic cancer	0.000116	0.00123	CcSEcCtD
Drospirenone—Gastrointestinal disorder—Fludarabine—hematologic cancer	0.000116	0.00122	CcSEcCtD
Drospirenone—Unspecified disorder of skin and subcutaneous tissue—Melphalan—hematologic cancer	0.000115	0.00121	CcSEcCtD
Drospirenone—Angiopathy—Thalidomide—hematologic cancer	0.000114	0.00121	CcSEcCtD
Drospirenone—Mental disorder—Thiotepa—hematologic cancer	0.000114	0.0012	CcSEcCtD
Drospirenone—Erythema multiforme—Alitretinoin—hematologic cancer	0.000113	0.00119	CcSEcCtD
Drospirenone—Haemoglobin—Mitoxantrone—hematologic cancer	0.000113	0.00119	CcSEcCtD
Drospirenone—Haemoglobin—Irinotecan—hematologic cancer	0.000113	0.00119	CcSEcCtD
Drospirenone—Haemorrhage—Mitoxantrone—hematologic cancer	0.000112	0.00119	CcSEcCtD
Drospirenone—Haemorrhage—Irinotecan—hematologic cancer	0.000112	0.00119	CcSEcCtD
Drospirenone—Acute coronary syndrome—Cisplatin—hematologic cancer	0.000112	0.00118	CcSEcCtD
Drospirenone—Erythema multiforme—Ifosfamide—hematologic cancer	0.000112	0.00118	CcSEcCtD
Drospirenone—Unspecified disorder of skin and subcutaneous tissue—Lenalidomide—hematologic cancer	0.000111	0.00118	CcSEcCtD
Drospirenone—Medroxyprogesterone Acetate—AR—hematologic cancer	0.000111	0.0487	CrCbGaD
Drospirenone—Myocardial infarction—Cisplatin—hematologic cancer	0.000111	0.00118	CcSEcCtD
Drospirenone—Breast pain—Doxorubicin—hematologic cancer	0.00011	0.00117	CcSEcCtD
Drospirenone—Mental disorder—Thalidomide—hematologic cancer	0.00011	0.00116	CcSEcCtD
Drospirenone—Unspecified disorder of skin and subcutaneous tissue—Hydroxyurea—hematologic cancer	0.00011	0.00116	CcSEcCtD
Drospirenone—Haemoglobin—Gemcitabine—hematologic cancer	0.00011	0.00116	CcSEcCtD
Drospirenone—Gastrointestinal disorder—Chlorambucil—hematologic cancer	0.000109	0.00116	CcSEcCtD
Drospirenone—Haemorrhage—Gemcitabine—hematologic cancer	0.000109	0.00116	CcSEcCtD
Drospirenone—Affect lability—Dexamethasone—hematologic cancer	0.000109	0.00116	CcSEcCtD
Drospirenone—Migraine—Betamethasone—hematologic cancer	0.000109	0.00116	CcSEcCtD
Drospirenone—Affect lability—Betamethasone—hematologic cancer	0.000109	0.00116	CcSEcCtD
Drospirenone—Migraine—Dexamethasone—hematologic cancer	0.000109	0.00116	CcSEcCtD
Drospirenone—Angiopathy—Alitretinoin—hematologic cancer	0.000108	0.00115	CcSEcCtD
Drospirenone—Skin disorder—Melphalan—hematologic cancer	0.000107	0.00114	CcSEcCtD
Drospirenone—Angiopathy—Ifosfamide—hematologic cancer	0.000107	0.00113	CcSEcCtD
Drospirenone—Gastrointestinal disorder—Nilotinib—hematologic cancer	0.000107	0.00113	CcSEcCtD
Drospirenone—Gastrointestinal disorder—Imatinib—hematologic cancer	0.000106	0.00113	CcSEcCtD
Drospirenone—Mental disorder—Carmustine—hematologic cancer	0.000106	0.00112	CcSEcCtD
Drospirenone—Nervous system disorder—Lenalidomide—hematologic cancer	0.000105	0.00112	CcSEcCtD
Drospirenone—Mood swings—Dexamethasone—hematologic cancer	0.000105	0.00111	CcSEcCtD
Drospirenone—Mood swings—Betamethasone—hematologic cancer	0.000105	0.00111	CcSEcCtD
Drospirenone—Mental disorder—Alitretinoin—hematologic cancer	0.000105	0.00111	CcSEcCtD
Drospirenone—Methyltestosterone—AR—hematologic cancer	0.000105	0.0458	CrCbGaD
Drospirenone—Gastrointestinal disorder—Cladribine—hematologic cancer	0.000105	0.00111	CcSEcCtD
Drospirenone—Angiopathy—Vincristine—hematologic cancer	0.000104	0.0011	CcSEcCtD
Drospirenone—Skin disorder—Lenalidomide—hematologic cancer	0.000104	0.0011	CcSEcCtD
Drospirenone—Nervous system disorder—Hydroxyurea—hematologic cancer	0.000104	0.0011	CcSEcCtD
Drospirenone—Nausea—Nelarabine—hematologic cancer	0.000103	0.00109	CcSEcCtD
Drospirenone—Mental disorder—Ifosfamide—hematologic cancer	0.000103	0.00109	CcSEcCtD
Drospirenone—Erythema multiforme—Gemcitabine—hematologic cancer	0.000103	0.00109	CcSEcCtD
Drospirenone—Skin disorder—Hydroxyurea—hematologic cancer	0.000103	0.00109	CcSEcCtD
Drospirenone—Unspecified disorder of skin and subcutaneous tissue—Bortezomib—hematologic cancer	0.000102	0.00108	CcSEcCtD
Drospirenone—Acute coronary syndrome—Etoposide—hematologic cancer	0.000102	0.00108	CcSEcCtD
Drospirenone—Myocardial infarction—Etoposide—hematologic cancer	0.000102	0.00108	CcSEcCtD
Drospirenone—Angiopathy—Irinotecan—hematologic cancer	0.000102	0.00108	CcSEcCtD
Drospirenone—Nausea—Methoxsalen—hematologic cancer	0.000101	0.00107	CcSEcCtD
Drospirenone—Acute coronary syndrome—Prednisolone—hematologic cancer	0.000101	0.00107	CcSEcCtD
Drospirenone—Mental disorder—Vincristine—hematologic cancer	0.000101	0.00107	CcSEcCtD
Drospirenone—Myocardial infarction—Prednisolone—hematologic cancer	0.0001	0.00106	CcSEcCtD
Drospirenone—Unspecified disorder of skin and subcutaneous tissue—Vinorelbine—hematologic cancer	0.0001	0.00106	CcSEcCtD
Drospirenone—Angiopathy—Gemcitabine—hematologic cancer	9.91e-05	0.00105	CcSEcCtD
Drospirenone—Nausea—Mercaptopurine—hematologic cancer	9.82e-05	0.00104	CcSEcCtD
Drospirenone—Nervous system disorder—Bortezomib—hematologic cancer	9.7e-05	0.00103	CcSEcCtD
Drospirenone—Nausea—Clofarabine—hematologic cancer	9.69e-05	0.00102	CcSEcCtD
Drospirenone—Nausea—Daunorubicin—hematologic cancer	9.69e-05	0.00102	CcSEcCtD
Drospirenone—Nausea—Pentostatin—hematologic cancer	9.64e-05	0.00102	CcSEcCtD
Drospirenone—Nausea—Anagrelide—hematologic cancer	9.64e-05	0.00102	CcSEcCtD
Drospirenone—Skin disorder—Bortezomib—hematologic cancer	9.61e-05	0.00102	CcSEcCtD
Drospirenone—Unspecified disorder of skin and subcutaneous tissue—Thiotepa—hematologic cancer	9.55e-05	0.00101	CcSEcCtD
Drospirenone—Gastrointestinal disorder—Melphalan—hematologic cancer	9.54e-05	0.00101	CcSEcCtD
Drospirenone—Affect lability—Prednisone—hematologic cancer	9.51e-05	0.00101	CcSEcCtD
Drospirenone—Nervous system disorder—Vinorelbine—hematologic cancer	9.47e-05	0.001	CcSEcCtD
Drospirenone—Skin disorder—Vinorelbine—hematologic cancer	9.38e-05	0.000992	CcSEcCtD
Drospirenone—Nausea—Idarubicin—hematologic cancer	9.3e-05	0.000984	CcSEcCtD
Drospirenone—Acute coronary syndrome—Triamcinolone—hematologic cancer	9.29e-05	0.000983	CcSEcCtD
Drospirenone—Gastrointestinal disorder—Lenalidomide—hematologic cancer	9.28e-05	0.000982	CcSEcCtD
Drospirenone—Haemoglobin—Prednisolone—hematologic cancer	9.24e-05	0.000978	CcSEcCtD
Drospirenone—Unspecified disorder of skin and subcutaneous tissue—Thalidomide—hematologic cancer	9.24e-05	0.000978	CcSEcCtD
Drospirenone—Myocardial infarction—Triamcinolone—hematologic cancer	9.23e-05	0.000977	CcSEcCtD
Drospirenone—Haemorrhage—Prednisolone—hematologic cancer	9.2e-05	0.000973	CcSEcCtD
Drospirenone—Mood swings—Prednisone—hematologic cancer	9.15e-05	0.000968	CcSEcCtD
Drospirenone—Gastrointestinal disorder—Hydroxyurea—hematologic cancer	9.15e-05	0.000968	CcSEcCtD
Drospirenone—Nausea—Teniposide—hematologic cancer	9.05e-05	0.000957	CcSEcCtD
Drospirenone—Nervous system disorder—Thiotepa—hematologic cancer	9.04e-05	0.000957	CcSEcCtD
Drospirenone—Skin disorder—Thiotepa—hematologic cancer	8.96e-05	0.000948	CcSEcCtD
Drospirenone—Erythema multiforme—Etoposide—hematologic cancer	8.82e-05	0.000933	CcSEcCtD
Drospirenone—Unspecified disorder of skin and subcutaneous tissue—Alitretinoin—hematologic cancer	8.79e-05	0.00093	CcSEcCtD
Drospirenone—Nervous system disorder—Thalidomide—hematologic cancer	8.75e-05	0.000925	CcSEcCtD
Drospirenone—Unspecified disorder of skin and subcutaneous tissue—Ifosfamide—hematologic cancer	8.69e-05	0.000919	CcSEcCtD
Drospirenone—Skin disorder—Thalidomide—hematologic cancer	8.66e-05	0.000917	CcSEcCtD
Drospirenone—Medroxyprogesterone Acetate—ESR1—hematologic cancer	8.56e-05	0.0375	CrCbGaD
Drospirenone—Gastrointestinal disorder—Bortezomib—hematologic cancer	8.54e-05	0.000903	CcSEcCtD
Drospirenone—Haemoglobin—Triamcinolone—hematologic cancer	8.5e-05	0.000899	CcSEcCtD
Drospirenone—Angiopathy—Etoposide—hematologic cancer	8.46e-05	0.000895	CcSEcCtD
Drospirenone—Haemorrhage—Triamcinolone—hematologic cancer	8.46e-05	0.000895	CcSEcCtD
Drospirenone—Acute coronary syndrome—Dexamethasone—hematologic cancer	8.43e-05	0.000892	CcSEcCtD
Drospirenone—Acute coronary syndrome—Betamethasone—hematologic cancer	8.43e-05	0.000892	CcSEcCtD
Drospirenone—Nausea—Busulfan—hematologic cancer	8.38e-05	0.000887	CcSEcCtD
Drospirenone—Myocardial infarction—Betamethasone—hematologic cancer	8.38e-05	0.000887	CcSEcCtD
Drospirenone—Myocardial infarction—Dexamethasone—hematologic cancer	8.38e-05	0.000887	CcSEcCtD
Drospirenone—Gastrointestinal disorder—Vinorelbine—hematologic cancer	8.34e-05	0.000882	CcSEcCtD
Drospirenone—Nervous system disorder—Alitretinoin—hematologic cancer	8.32e-05	0.000881	CcSEcCtD
Drospirenone—Skin disorder—Alitretinoin—hematologic cancer	8.24e-05	0.000872	CcSEcCtD
Drospirenone—Cerebrovascular accident—Methotrexate—hematologic cancer	8.24e-05	0.000872	CcSEcCtD
Drospirenone—Nervous system disorder—Ifosfamide—hematologic cancer	8.23e-05	0.00087	CcSEcCtD
Drospirenone—Skin disorder—Ifosfamide—hematologic cancer	8.15e-05	0.000862	CcSEcCtD
Drospirenone—Nausea—Procarbazine—hematologic cancer	8.13e-05	0.00086	CcSEcCtD
Drospirenone—Spironolactone—NR3C1—hematologic cancer	8.05e-05	0.0353	CrCbGaD
Drospirenone—Unspecified disorder of skin and subcutaneous tissue—Gemcitabine—hematologic cancer	8.04e-05	0.00085	CcSEcCtD
Drospirenone—Nervous system disorder—Vincristine—hematologic cancer	8.02e-05	0.000848	CcSEcCtD
Drospirenone—Nausea—Dasatinib—hematologic cancer	7.97e-05	0.000843	CcSEcCtD
Drospirenone—Nausea—Bexarotene—hematologic cancer	7.97e-05	0.000843	CcSEcCtD
Drospirenone—Gastrointestinal disorder—Thiotepa—hematologic cancer	7.96e-05	0.000842	CcSEcCtD
Drospirenone—Nausea—Fludarabine—hematologic cancer	7.95e-05	0.000841	CcSEcCtD
Drospirenone—Nervous system disorder—Irinotecan—hematologic cancer	7.81e-05	0.000826	CcSEcCtD
Drospirenone—Skin disorder—Mitoxantrone—hematologic cancer	7.74e-05	0.000818	CcSEcCtD
Drospirenone—Haemoglobin—Betamethasone—hematologic cancer	7.71e-05	0.000816	CcSEcCtD
Drospirenone—Haemoglobin—Dexamethasone—hematologic cancer	7.71e-05	0.000816	CcSEcCtD
Drospirenone—Cerebrovascular accident—Epirubicin—hematologic cancer	7.71e-05	0.000816	CcSEcCtD
Drospirenone—Gastrointestinal disorder—Thalidomide—hematologic cancer	7.7e-05	0.000815	CcSEcCtD
Drospirenone—Haemorrhage—Betamethasone—hematologic cancer	7.67e-05	0.000812	CcSEcCtD
Drospirenone—Haemorrhage—Dexamethasone—hematologic cancer	7.67e-05	0.000812	CcSEcCtD
Drospirenone—Mood swings—Methotrexate—hematologic cancer	7.65e-05	0.000809	CcSEcCtD
Drospirenone—Nervous system disorder—Gemcitabine—hematologic cancer	7.61e-05	0.000805	CcSEcCtD
Drospirenone—Medroxyprogesterone Acetate—NR3C1—hematologic cancer	7.54e-05	0.033	CrCbGaD
Drospirenone—Skin disorder—Gemcitabine—hematologic cancer	7.54e-05	0.000797	CcSEcCtD
Drospirenone—Nausea—Chlorambucil—hematologic cancer	7.53e-05	0.000797	CcSEcCtD
Drospirenone—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—hematologic cancer	7.49e-05	0.000793	CcSEcCtD
Drospirenone—Affect lability—Epirubicin—hematologic cancer	7.44e-05	0.000787	CcSEcCtD
Drospirenone—Migraine—Epirubicin—hematologic cancer	7.44e-05	0.000787	CcSEcCtD
Drospirenone—Depression—Prednisone—hematologic cancer	7.42e-05	0.000785	CcSEcCtD
Drospirenone—Gastrointestinal disorder—Carmustine—hematologic cancer	7.4e-05	0.000782	CcSEcCtD
Drospirenone—Nausea—Nilotinib—hematologic cancer	7.37e-05	0.000779	CcSEcCtD
Drospirenone—Acute coronary syndrome—Prednisone—hematologic cancer	7.34e-05	0.000776	CcSEcCtD
Drospirenone—Gastrointestinal disorder—Alitretinoin—hematologic cancer	7.33e-05	0.000775	CcSEcCtD
Drospirenone—Nausea—Imatinib—hematologic cancer	7.32e-05	0.000775	CcSEcCtD
Drospirenone—Myocardial infarction—Prednisone—hematologic cancer	7.3e-05	0.000772	CcSEcCtD
Drospirenone—Breast disorder—Methotrexate—hematologic cancer	7.3e-05	0.000772	CcSEcCtD
Drospirenone—Gastrointestinal disorder—Ifosfamide—hematologic cancer	7.24e-05	0.000766	CcSEcCtD
Drospirenone—Progesterone—SLC22A1—hematologic cancer	7.23e-05	0.0317	CrCbGaD
Drospirenone—Nausea—Cladribine—hematologic cancer	7.2e-05	0.000761	CcSEcCtD
Drospirenone—Mood swings—Epirubicin—hematologic cancer	7.16e-05	0.000757	CcSEcCtD
Drospirenone—Cerebrovascular accident—Doxorubicin—hematologic cancer	7.13e-05	0.000755	CcSEcCtD
Drospirenone—Nervous system disorder—Cisplatin—hematologic cancer	7.09e-05	0.00075	CcSEcCtD
Drospirenone—Gastrointestinal disorder—Vincristine—hematologic cancer	7.06e-05	0.000747	CcSEcCtD
Drospirenone—Skin disorder—Cisplatin—hematologic cancer	7.02e-05	0.000743	CcSEcCtD
Drospirenone—Angiopathy—Dexamethasone—hematologic cancer	6.96e-05	0.000737	CcSEcCtD
Drospirenone—Angiopathy—Betamethasone—hematologic cancer	6.96e-05	0.000737	CcSEcCtD
Drospirenone—Nausea—Vinblastine—hematologic cancer	6.9e-05	0.00073	CcSEcCtD
Drospirenone—Affect lability—Doxorubicin—hematologic cancer	6.88e-05	0.000728	CcSEcCtD
Drospirenone—Migraine—Doxorubicin—hematologic cancer	6.88e-05	0.000728	CcSEcCtD
Drospirenone—Gastrointestinal disorder—Irinotecan—hematologic cancer	6.88e-05	0.000727	CcSEcCtD
Drospirenone—Unspecified disorder of skin and subcutaneous tissue—Etoposide—hematologic cancer	6.86e-05	0.000726	CcSEcCtD
Drospirenone—Testosterone—SLC22A1—hematologic cancer	6.83e-05	0.0299	CrCbGaD
Drospirenone—Breast disorder—Epirubicin—hematologic cancer	6.83e-05	0.000722	CcSEcCtD
Drospirenone—Haemoglobin—Prednisone—hematologic cancer	6.72e-05	0.000711	CcSEcCtD
Drospirenone—Gastrointestinal disorder—Gemcitabine—hematologic cancer	6.7e-05	0.000709	CcSEcCtD
Drospirenone—Haemorrhage—Prednisone—hematologic cancer	6.68e-05	0.000707	CcSEcCtD
Drospirenone—Mood swings—Doxorubicin—hematologic cancer	6.62e-05	0.000701	CcSEcCtD
Drospirenone—Nausea—Melphalan—hematologic cancer	6.57e-05	0.000695	CcSEcCtD
Drospirenone—Skin disorder—Etoposide—hematologic cancer	6.43e-05	0.000681	CcSEcCtD
Drospirenone—Progesterone—AR—hematologic cancer	6.42e-05	0.0281	CrCbGaD
Drospirenone—Nausea—Lenalidomide—hematologic cancer	6.38e-05	0.000675	CcSEcCtD
Drospirenone—Breast disorder—Doxorubicin—hematologic cancer	6.32e-05	0.000668	CcSEcCtD
Drospirenone—Nausea—Hydroxyurea—hematologic cancer	6.29e-05	0.000666	CcSEcCtD
Drospirenone—Megestrol acetate—ABCB1—hematologic cancer	6.24e-05	0.0274	CrCbGaD
Drospirenone—Gastrointestinal disorder—Cisplatin—hematologic cancer	6.24e-05	0.00066	CcSEcCtD
Drospirenone—Depression—Methotrexate—hematologic cancer	6.2e-05	0.000656	CcSEcCtD
Drospirenone—Hydrocortisone—ABCG2—hematologic cancer	6.2e-05	0.0271	CrCbGaD
Drospirenone—Testosterone—AR—hematologic cancer	6.07e-05	0.0266	CrCbGaD
Drospirenone—Angiopathy—Prednisone—hematologic cancer	6.06e-05	0.000641	CcSEcCtD
Drospirenone—Nausea—Bortezomib—hematologic cancer	5.87e-05	0.000622	CcSEcCtD
Drospirenone—Mental disorder—Prednisone—hematologic cancer	5.85e-05	0.000619	CcSEcCtD
Drospirenone—Nausea—Bleomycin—hematologic cancer	5.83e-05	0.000617	CcSEcCtD
Drospirenone—Nausea—Vinorelbine—hematologic cancer	5.74e-05	0.000607	CcSEcCtD
Drospirenone—Gastrointestinal disorder—Etoposide—hematologic cancer	5.72e-05	0.000605	CcSEcCtD
Drospirenone—Haemoglobin—Methotrexate—hematologic cancer	5.61e-05	0.000594	CcSEcCtD
Drospirenone—Haemorrhage—Methotrexate—hematologic cancer	5.59e-05	0.000591	CcSEcCtD
Drospirenone—Nausea—Thiotepa—hematologic cancer	5.48e-05	0.00058	CcSEcCtD
Drospirenone—Nervous system disorder—Dexamethasone—hematologic cancer	5.35e-05	0.000566	CcSEcCtD
Drospirenone—Nervous system disorder—Betamethasone—hematologic cancer	5.35e-05	0.000566	CcSEcCtD
Drospirenone—Hydrocortisone—NR3C1—hematologic cancer	5.34e-05	0.0234	CrCbGaD
Drospirenone—Nausea—Thalidomide—hematologic cancer	5.3e-05	0.000561	CcSEcCtD
Drospirenone—Erythema multiforme—Methotrexate—hematologic cancer	5.28e-05	0.000559	CcSEcCtD
Drospirenone—Haemoglobin—Epirubicin—hematologic cancer	5.25e-05	0.000556	CcSEcCtD
Drospirenone—Haemorrhage—Epirubicin—hematologic cancer	5.23e-05	0.000553	CcSEcCtD
Drospirenone—Nausea—Carmustine—hematologic cancer	5.09e-05	0.000538	CcSEcCtD
Drospirenone—Angiopathy—Methotrexate—hematologic cancer	5.07e-05	0.000536	CcSEcCtD
Drospirenone—Nausea—Alitretinoin—hematologic cancer	5.04e-05	0.000533	CcSEcCtD
Drospirenone—Nausea—Ifosfamide—hematologic cancer	4.98e-05	0.000527	CcSEcCtD
Drospirenone—Progesterone—ESR1—hematologic cancer	4.95e-05	0.0217	CrCbGaD
Drospirenone—Erythema multiforme—Epirubicin—hematologic cancer	4.94e-05	0.000523	CcSEcCtD
Drospirenone—Unspecified disorder of skin and subcutaneous tissue—Prednisone—hematologic cancer	4.92e-05	0.00052	CcSEcCtD
Drospirenone—Mental disorder—Methotrexate—hematologic cancer	4.89e-05	0.000518	CcSEcCtD
Drospirenone—Haemoglobin—Doxorubicin—hematologic cancer	4.86e-05	0.000514	CcSEcCtD
Drospirenone—Nausea—Vincristine—hematologic cancer	4.86e-05	0.000514	CcSEcCtD
Drospirenone—Haemorrhage—Doxorubicin—hematologic cancer	4.84e-05	0.000512	CcSEcCtD
Drospirenone—Testosterone—ABCG2—hematologic cancer	4.77e-05	0.0209	CrCbGaD
Drospirenone—Angiopathy—Epirubicin—hematologic cancer	4.74e-05	0.000502	CcSEcCtD
Drospirenone—Nausea—Irinotecan—hematologic cancer	4.73e-05	0.0005	CcSEcCtD
Drospirenone—Nausea—Mitoxantrone—hematologic cancer	4.73e-05	0.0005	CcSEcCtD
Drospirenone—Gastrointestinal disorder—Dexamethasone—hematologic cancer	4.71e-05	0.000498	CcSEcCtD
Drospirenone—Gastrointestinal disorder—Betamethasone—hematologic cancer	4.71e-05	0.000498	CcSEcCtD
Drospirenone—Nervous system disorder—Prednisone—hematologic cancer	4.66e-05	0.000493	CcSEcCtD
Drospirenone—Skin disorder—Prednisone—hematologic cancer	4.61e-05	0.000488	CcSEcCtD
Drospirenone—Nausea—Gemcitabine—hematologic cancer	4.61e-05	0.000488	CcSEcCtD
Drospirenone—Mental disorder—Epirubicin—hematologic cancer	4.58e-05	0.000484	CcSEcCtD
Drospirenone—Erythema multiforme—Doxorubicin—hematologic cancer	4.57e-05	0.000484	CcSEcCtD
Drospirenone—Angiopathy—Doxorubicin—hematologic cancer	4.39e-05	0.000464	CcSEcCtD
Drospirenone—Progesterone—NR3C1—hematologic cancer	4.35e-05	0.0191	CrCbGaD
Drospirenone—Nausea—Cisplatin—hematologic cancer	4.3e-05	0.000454	CcSEcCtD
Drospirenone—Mental disorder—Doxorubicin—hematologic cancer	4.24e-05	0.000448	CcSEcCtD
Drospirenone—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—hematologic cancer	4.11e-05	0.000435	CcSEcCtD
Drospirenone—Nausea—Etoposide—hematologic cancer	3.93e-05	0.000416	CcSEcCtD
Drospirenone—Nervous system disorder—Methotrexate—hematologic cancer	3.89e-05	0.000412	CcSEcCtD
Drospirenone—Spironolactone—ABCB1—hematologic cancer	3.88e-05	0.017	CrCbGaD
Drospirenone—Nausea—Prednisolone—hematologic cancer	3.88e-05	0.000411	CcSEcCtD
Drospirenone—Skin disorder—Methotrexate—hematologic cancer	3.85e-05	0.000408	CcSEcCtD
Drospirenone—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—hematologic cancer	3.85e-05	0.000407	CcSEcCtD
Drospirenone—Norethindrone—ALB—hematologic cancer	3.78e-05	0.0166	CrCbGaD
Drospirenone—Nervous system disorder—Epirubicin—hematologic cancer	3.64e-05	0.000385	CcSEcCtD
Drospirenone—Skin disorder—Epirubicin—hematologic cancer	3.61e-05	0.000382	CcSEcCtD
Drospirenone—Norethindrone—ABCB1—hematologic cancer	3.61e-05	0.0158	CrCbGaD
Drospirenone—Methyltestosterone—ALB—hematologic cancer	3.59e-05	0.0157	CrCbGaD
Drospirenone—Nausea—Triamcinolone—hematologic cancer	3.57e-05	0.000378	CcSEcCtD
Drospirenone—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—hematologic cancer	3.56e-05	0.000377	CcSEcCtD
Drospirenone—Gastrointestinal disorder—Methotrexate—hematologic cancer	3.43e-05	0.000362	CcSEcCtD
Drospirenone—Nervous system disorder—Doxorubicin—hematologic cancer	3.37e-05	0.000356	CcSEcCtD
Drospirenone—Skin disorder—Doxorubicin—hematologic cancer	3.34e-05	0.000353	CcSEcCtD
Drospirenone—Nausea—Dexamethasone—hematologic cancer	3.24e-05	0.000343	CcSEcCtD
Drospirenone—Nausea—Betamethasone—hematologic cancer	3.24e-05	0.000343	CcSEcCtD
Drospirenone—Gastrointestinal disorder—Epirubicin—hematologic cancer	3.21e-05	0.000339	CcSEcCtD
Drospirenone—Gastrointestinal disorder—Doxorubicin—hematologic cancer	2.97e-05	0.000314	CcSEcCtD
Drospirenone—Nausea—Prednisone—hematologic cancer	2.82e-05	0.000298	CcSEcCtD
Drospirenone—Hydrocortisone—ABCB1—hematologic cancer	2.58e-05	0.0113	CrCbGaD
Drospirenone—Nausea—Methotrexate—hematologic cancer	2.36e-05	0.000249	CcSEcCtD
Drospirenone—Nausea—Epirubicin—hematologic cancer	2.21e-05	0.000233	CcSEcCtD
Drospirenone—Progesterone—ABCB1—hematologic cancer	2.1e-05	0.00921	CrCbGaD
Drospirenone—Testosterone—ALB—hematologic cancer	2.08e-05	0.00912	CrCbGaD
Drospirenone—Nausea—Doxorubicin—hematologic cancer	2.04e-05	0.000216	CcSEcCtD
Drospirenone—Testosterone—ABCB1—hematologic cancer	1.99e-05	0.0087	CrCbGaD
Drospirenone—BCHE—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	8.15e-06	0.000145	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism of lipids and lipoproteins—NCOR1—hematologic cancer	8.15e-06	0.000145	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—ARNTL—hematologic cancer	8.13e-06	0.000144	CbGpPWpGaD
Drospirenone—AR—Gene Expression—NCOR1—hematologic cancer	8.12e-06	0.000144	CbGpPWpGaD
Drospirenone—PTGS2—Disease—NPM1—hematologic cancer	8.1e-06	0.000144	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—SDC1—hematologic cancer	8.09e-06	0.000144	CbGpPWpGaD
Drospirenone—PGR—Gene Expression—NOTCH1—hematologic cancer	8.09e-06	0.000144	CbGpPWpGaD
Drospirenone—PTGS2—Integrated Pancreatic Cancer Pathway—MYC—hematologic cancer	7.98e-06	0.000142	CbGpPWpGaD
Drospirenone—PTGS2—Integrated Pancreatic Cancer Pathway—TGFB1—hematologic cancer	7.96e-06	0.000141	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—CA9—hematologic cancer	7.91e-06	0.00014	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—ACP5—hematologic cancer	7.91e-06	0.00014	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—NCOR2—hematologic cancer	7.8e-06	0.000139	CbGpPWpGaD
Drospirenone—PTGS2—Disease—FGF19—hematologic cancer	7.76e-06	0.000138	CbGpPWpGaD
Drospirenone—BCHE—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	7.73e-06	0.000137	CbGpPWpGaD
Drospirenone—PTGS2—Disease—RPS14—hematologic cancer	7.7e-06	0.000137	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—GRB2—hematologic cancer	7.67e-06	0.000136	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—PDGFA—hematologic cancer	7.65e-06	0.000136	CbGpPWpGaD
Drospirenone—PTGS2—Disease—DKK1—hematologic cancer	7.63e-06	0.000136	CbGpPWpGaD
Drospirenone—BCHE—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	7.63e-06	0.000136	CbGpPWpGaD
Drospirenone—PTGS2—Disease—STAT5B—hematologic cancer	7.58e-06	0.000135	CbGpPWpGaD
Drospirenone—PTGS2—Disease—NUP98—hematologic cancer	7.58e-06	0.000135	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—KITLG—hematologic cancer	7.54e-06	0.000134	CbGpPWpGaD
Drospirenone—AR—Gene Expression—NR3C1—hematologic cancer	7.51e-06	0.000133	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—IDH1—hematologic cancer	7.43e-06	0.000132	CbGpPWpGaD
Drospirenone—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—hematologic cancer	7.43e-06	0.000132	CbGpPWpGaD
Drospirenone—PTGS2—Disease—CST3—hematologic cancer	7.41e-06	0.000132	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—STAT5A—hematologic cancer	7.37e-06	0.000131	CbGpPWpGaD
Drospirenone—PTGS2—Integrated Pancreatic Cancer Pathway—KRAS—hematologic cancer	7.37e-06	0.000131	CbGpPWpGaD
Drospirenone—PTGS2—Disease—ADCY7—hematologic cancer	7.35e-06	0.000131	CbGpPWpGaD
Drospirenone—NR3C2—Gene Expression—MAPK3—hematologic cancer	7.35e-06	0.000131	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—TXN—hematologic cancer	7.35e-06	0.000131	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—ABCC3—hematologic cancer	7.35e-06	0.000131	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—GSTO1—hematologic cancer	7.35e-06	0.000131	CbGpPWpGaD
Drospirenone—PGR—Gene Expression—CREBBP—hematologic cancer	7.34e-06	0.00013	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—CDKN2B—hematologic cancer	7.31e-06	0.00013	CbGpPWpGaD
Drospirenone—PTGS2—Disease—NUP214—hematologic cancer	7.3e-06	0.00013	CbGpPWpGaD
Drospirenone—BCHE—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	7.3e-06	0.00013	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—SPHK1—hematologic cancer	7.19e-06	0.000128	CbGpPWpGaD
Drospirenone—PTGS2—Disease—XIAP—hematologic cancer	7.15e-06	0.000127	CbGpPWpGaD
Drospirenone—PTGS2—Disease—MTR—hematologic cancer	7.15e-06	0.000127	CbGpPWpGaD
Drospirenone—NR3C2—Gene Expression—MYC—hematologic cancer	7.15e-06	0.000127	CbGpPWpGaD
Drospirenone—BCHE—Metabolism of proteins—CCL2—hematologic cancer	7.08e-06	0.000126	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—CD86—hematologic cancer	7.07e-06	0.000125	CbGpPWpGaD
Drospirenone—PTGS2—Disease—ENO2—hematologic cancer	7.02e-06	0.000125	CbGpPWpGaD
Drospirenone—PTGS2—Disease—SMARCA4—hematologic cancer	6.97e-06	0.000124	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—HES1—hematologic cancer	6.97e-06	0.000124	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—NCOR1—hematologic cancer	6.93e-06	0.000123	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—UGT1A1—hematologic cancer	6.91e-06	0.000123	CbGpPWpGaD
Drospirenone—AR—Generic Transcription Pathway—MYC—hematologic cancer	6.89e-06	0.000122	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—NQO1—hematologic cancer	6.88e-06	0.000122	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—CD44—hematologic cancer	6.88e-06	0.000122	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—CSF2—hematologic cancer	6.85e-06	0.000122	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—FGF1—hematologic cancer	6.85e-06	0.000122	CbGpPWpGaD
Drospirenone—PTGS2—Integrated Pancreatic Cancer Pathway—PIK3CA—hematologic cancer	6.77e-06	0.00012	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—FOXO1—hematologic cancer	6.75e-06	0.00012	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—PDGFRB—hematologic cancer	6.74e-06	0.00012	CbGpPWpGaD
Drospirenone—BCHE—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	6.74e-06	0.00012	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—CRABP1—hematologic cancer	6.72e-06	0.000119	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—SLC22A1—hematologic cancer	6.72e-06	0.000119	CbGpPWpGaD
Drospirenone—BCHE—Neuronal System—HRAS—hematologic cancer	6.72e-06	0.000119	CbGpPWpGaD
Drospirenone—PTGS2—Disease—SDC1—hematologic cancer	6.65e-06	0.000118	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—PDGFRA—hematologic cancer	6.64e-06	0.000118	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—JAK1—hematologic cancer	6.61e-06	0.000117	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—PRKCG—hematologic cancer	6.61e-06	0.000117	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—ALOX5—hematologic cancer	6.55e-06	0.000116	CbGpPWpGaD
Drospirenone—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—hematologic cancer	6.55e-06	0.000116	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—CYCS—hematologic cancer	6.51e-06	0.000116	CbGpPWpGaD
Drospirenone—AR—Gene Expression—MAPK14—hematologic cancer	6.5e-06	0.000115	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—HSP90AA1—hematologic cancer	6.47e-06	0.000115	CbGpPWpGaD
Drospirenone—PTGS2—Disease—LCK—hematologic cancer	6.44e-06	0.000114	CbGpPWpGaD
Drospirenone—AR—Gene Expression—ESR1—hematologic cancer	6.38e-06	0.000113	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—NUP98—hematologic cancer	6.34e-06	0.000113	CbGpPWpGaD
Drospirenone—PTGS2—Disease—H3F3A—hematologic cancer	6.31e-06	0.000112	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—IL2RA—hematologic cancer	6.18e-06	0.00011	CbGpPWpGaD
Drospirenone—AR—Gene Expression—NOTCH1—hematologic cancer	6.17e-06	0.000109	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—NCOA3—hematologic cancer	6.16e-06	0.000109	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—ADCY7—hematologic cancer	6.16e-06	0.000109	CbGpPWpGaD
Drospirenone—PTGS2—Disease—PRKCZ—hematologic cancer	6.14e-06	0.000109	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—NUP214—hematologic cancer	6.12e-06	0.000109	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—TERT—hematologic cancer	6.11e-06	0.000108	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	6.05e-06	0.000107	CbGpPWpGaD
Drospirenone—PTGS2—Disease—CALR—hematologic cancer	6.03e-06	0.000107	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—MTR—hematologic cancer	5.99e-06	0.000106	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—ABCG2—hematologic cancer	5.99e-06	0.000106	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—PDGFB—hematologic cancer	5.96e-06	0.000106	CbGpPWpGaD
Drospirenone—PTGS2—Disease—PARP1—hematologic cancer	5.93e-06	0.000105	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—ENO2—hematologic cancer	5.88e-06	0.000104	CbGpPWpGaD
Drospirenone—PTGS2—Disease—FBXW7—hematologic cancer	5.83e-06	0.000104	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—TSC2—hematologic cancer	5.83e-06	0.000103	CbGpPWpGaD
Drospirenone—BCHE—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	5.82e-06	0.000103	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—GSTP1—hematologic cancer	5.74e-06	0.000102	CbGpPWpGaD
Drospirenone—PTGS2—Disease—HDAC2—hematologic cancer	5.72e-06	0.000102	CbGpPWpGaD
Drospirenone—PTGS2—Disease—CXCR4—hematologic cancer	5.72e-06	0.000102	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—GSTT1—hematologic cancer	5.7e-06	0.000101	CbGpPWpGaD
Drospirenone—PTGS2—Disease—CD44—hematologic cancer	5.66e-06	0.0001	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	5.61e-06	9.97e-05	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—FGFR3—hematologic cancer	5.6e-06	9.95e-05	CbGpPWpGaD
Drospirenone—AR—Gene Expression—CREBBP—hematologic cancer	5.59e-06	9.93e-05	CbGpPWpGaD
Drospirenone—PTGS2—Disease—CBL—hematologic cancer	5.57e-06	9.9e-05	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—SDC1—hematologic cancer	5.57e-06	9.89e-05	CbGpPWpGaD
Drospirenone—BCHE—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	5.55e-06	9.86e-05	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—MAPK14—hematologic cancer	5.55e-06	9.85e-05	CbGpPWpGaD
Drospirenone—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—hematologic cancer	5.53e-06	9.82e-05	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—ESR1—hematologic cancer	5.44e-06	9.67e-05	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—ABCB1—hematologic cancer	5.43e-06	9.65e-05	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—FN1—hematologic cancer	5.38e-06	9.55e-05	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	5.32e-06	9.45e-05	CbGpPWpGaD
Drospirenone—PTGS2—Disease—HSP90AA1—hematologic cancer	5.32e-06	9.44e-05	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—BAD—hematologic cancer	5.31e-06	9.43e-05	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—NFKBIA—hematologic cancer	5.31e-06	9.43e-05	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—GSTM1—hematologic cancer	5.27e-06	9.37e-05	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—NCOR1—hematologic cancer	5.27e-06	9.37e-05	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—NOTCH1—hematologic cancer	5.26e-06	9.34e-05	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	5.25e-06	9.33e-05	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—CD80—hematologic cancer	5.15e-06	9.15e-05	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—KIT—hematologic cancer	5.15e-06	9.14e-05	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—PIK3CG—hematologic cancer	5.15e-06	9.14e-05	CbGpPWpGaD
Drospirenone—PTGS2—Disease—STAT1—hematologic cancer	5.13e-06	9.11e-05	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—PTPN11—hematologic cancer	5.05e-06	8.98e-05	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	5.02e-06	8.92e-05	CbGpPWpGaD
Drospirenone—NR3C2—Gene Expression—AKT1—hematologic cancer	4.96e-06	8.8e-05	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—CREB1—hematologic cancer	4.9e-06	8.7e-05	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—BRAF—hematologic cancer	4.84e-06	8.59e-05	CbGpPWpGaD
Drospirenone—PTGS2—Disease—GRB2—hematologic cancer	4.8e-06	8.52e-05	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—CCL2—hematologic cancer	4.79e-06	8.51e-05	CbGpPWpGaD
Drospirenone—PTGS2—Disease—PDGFA—hematologic cancer	4.79e-06	8.5e-05	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—IL6R—hematologic cancer	4.78e-06	8.48e-05	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—CREBBP—hematologic cancer	4.77e-06	8.47e-05	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—NQO1—hematologic cancer	4.74e-06	8.41e-05	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—CD44—hematologic cancer	4.74e-06	8.41e-05	CbGpPWpGaD
Drospirenone—PTGS2—Disease—KITLG—hematologic cancer	4.72e-06	8.38e-05	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—MTHFR—hematologic cancer	4.66e-06	8.28e-05	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	4.64e-06	8.24e-05	CbGpPWpGaD
Drospirenone—PTGS2—Disease—STAT5A—hematologic cancer	4.61e-06	8.19e-05	CbGpPWpGaD
Drospirenone—PTGS2—Disease—CDKN2B—hematologic cancer	4.57e-06	8.12e-05	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—MAP2K1—hematologic cancer	4.55e-06	8.09e-05	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—PIK3CD—hematologic cancer	4.52e-06	8.03e-05	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—CYCS—hematologic cancer	4.48e-06	7.96e-05	CbGpPWpGaD
Drospirenone—PGR—Gene Expression—MAPK3—hematologic cancer	4.48e-06	7.95e-05	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—HSP90AA1—hematologic cancer	4.45e-06	7.91e-05	CbGpPWpGaD
Drospirenone—PTGS2—Disease—CD86—hematologic cancer	4.42e-06	7.85e-05	CbGpPWpGaD
Drospirenone—PTGS2—Disease—HES1—hematologic cancer	4.36e-06	7.74e-05	CbGpPWpGaD
Drospirenone—PGR—Gene Expression—MYC—hematologic cancer	4.35e-06	7.73e-05	CbGpPWpGaD
Drospirenone—PTGS2—Disease—NCOR1—hematologic cancer	4.33e-06	7.7e-05	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—FGF2—hematologic cancer	4.33e-06	7.69e-05	CbGpPWpGaD
Drospirenone—PTGS2—Disease—FGF1—hematologic cancer	4.29e-06	7.61e-05	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—PIK3R1—hematologic cancer	4.27e-06	7.58e-05	CbGpPWpGaD
Drospirenone—PTGS2—Disease—FOXO1—hematologic cancer	4.22e-06	7.5e-05	CbGpPWpGaD
Drospirenone—PTGS2—Disease—PDGFRB—hematologic cancer	4.22e-06	7.49e-05	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—JAK2—hematologic cancer	4.15e-06	7.37e-05	CbGpPWpGaD
Drospirenone—PTGS2—Disease—PDGFRA—hematologic cancer	4.15e-06	7.37e-05	CbGpPWpGaD
Drospirenone—PTGS2—Disease—PRKCG—hematologic cancer	4.14e-06	7.35e-05	CbGpPWpGaD
Drospirenone—PTGS2—Disease—JAK1—hematologic cancer	4.14e-06	7.35e-05	CbGpPWpGaD
Drospirenone—BCHE—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	4.11e-06	7.29e-05	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—MDM2—hematologic cancer	4.05e-06	7.2e-05	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	4.01e-06	7.12e-05	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—GSTP1—hematologic cancer	3.95e-06	7.01e-05	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—MTOR—hematologic cancer	3.94e-06	7e-05	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—PIK3CB—hematologic cancer	3.94e-06	7e-05	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—PIK3CG—hematologic cancer	3.92e-06	6.95e-05	CbGpPWpGaD
Drospirenone—PTGS2—Disease—MTHFR—hematologic cancer	3.83e-06	6.8e-05	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	3.82e-06	6.79e-05	CbGpPWpGaD
Drospirenone—PTGS2—Disease—TERT—hematologic cancer	3.82e-06	6.78e-05	CbGpPWpGaD
Drospirenone—PTGS2—Disease—HLA-A—hematologic cancer	3.82e-06	6.78e-05	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—ABCB1—hematologic cancer	3.74e-06	6.64e-05	CbGpPWpGaD
Drospirenone—PTGS2—Disease—PDGFB—hematologic cancer	3.73e-06	6.62e-05	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—CDKN1B—hematologic cancer	3.7e-06	6.57e-05	CbGpPWpGaD
Drospirenone—PTGS2—Disease—TSC2—hematologic cancer	3.64e-06	6.47e-05	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—CREBBP—hematologic cancer	3.63e-06	6.45e-05	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—NCOR1—hematologic cancer	3.63e-06	6.45e-05	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—GSTM1—hematologic cancer	3.63e-06	6.45e-05	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—CASP3—hematologic cancer	3.63e-06	6.44e-05	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—IL2—hematologic cancer	3.62e-06	6.43e-05	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—CCND1—hematologic cancer	3.53e-06	6.27e-05	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—JUN—hematologic cancer	3.52e-06	6.25e-05	CbGpPWpGaD
Drospirenone—PTGS2—Disease—FGFR3—hematologic cancer	3.51e-06	6.23e-05	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—PIK3CD—hematologic cancer	3.44e-06	6.11e-05	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—CDKN1A—hematologic cancer	3.41e-06	6.06e-05	CbGpPWpGaD
Drospirenone—AR—Gene Expression—MAPK3—hematologic cancer	3.41e-06	6.06e-05	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—PTEN—hematologic cancer	3.41e-06	6.05e-05	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—ALB—hematologic cancer	3.4e-06	6.04e-05	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—MAPK8—hematologic cancer	3.33e-06	5.92e-05	CbGpPWpGaD
Drospirenone—PTGS2—Disease—BAD—hematologic cancer	3.32e-06	5.9e-05	CbGpPWpGaD
Drospirenone—AR—Gene Expression—MYC—hematologic cancer	3.32e-06	5.89e-05	CbGpPWpGaD
Drospirenone—PTGS2—Disease—NOTCH1—hematologic cancer	3.29e-06	5.84e-05	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—PIK3R1—hematologic cancer	3.25e-06	5.77e-05	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—EP300—hematologic cancer	3.25e-06	5.77e-05	CbGpPWpGaD
Drospirenone—PTGS2—Disease—CD80—hematologic cancer	3.22e-06	5.73e-05	CbGpPWpGaD
Drospirenone—PTGS2—Disease—KIT—hematologic cancer	3.22e-06	5.72e-05	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—MTHFR—hematologic cancer	3.21e-06	5.7e-05	CbGpPWpGaD
Drospirenone—PTGS2—Disease—PTPN11—hematologic cancer	3.16e-06	5.62e-05	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—SRC—hematologic cancer	3.16e-06	5.61e-05	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—VEGFA—hematologic cancer	3.08e-06	5.46e-05	CbGpPWpGaD
Drospirenone—PTGS2—Disease—CREB1—hematologic cancer	3.06e-06	5.44e-05	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—STAT3—hematologic cancer	3.05e-06	5.41e-05	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—NRAS—hematologic cancer	3.04e-06	5.4e-05	CbGpPWpGaD
Drospirenone—PTGS2—Disease—BRAF—hematologic cancer	3.03e-06	5.37e-05	CbGpPWpGaD
Drospirenone—PGR—Gene Expression—AKT1—hematologic cancer	3.02e-06	5.36e-05	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—PIK3CB—hematologic cancer	3e-06	5.33e-05	CbGpPWpGaD
Drospirenone—PTGS2—Disease—IL6R—hematologic cancer	2.99e-06	5.31e-05	CbGpPWpGaD
Drospirenone—PTGS2—Disease—CREBBP—hematologic cancer	2.98e-06	5.3e-05	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—MAPK3—hematologic cancer	2.91e-06	5.17e-05	CbGpPWpGaD
Drospirenone—PTGS2—Disease—MAP2K1—hematologic cancer	2.85e-06	5.06e-05	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—MYC—hematologic cancer	2.83e-06	5.03e-05	CbGpPWpGaD
Drospirenone—PTGS2—Disease—PIK3CD—hematologic cancer	2.83e-06	5.02e-05	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	2.83e-06	5.02e-05	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—TGFB1—hematologic cancer	2.82e-06	5.02e-05	CbGpPWpGaD
Drospirenone—PTGS2—Disease—FGF2—hematologic cancer	2.71e-06	4.81e-05	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—PIK3CG—hematologic cancer	2.7e-06	4.79e-05	CbGpPWpGaD
Drospirenone—PTGS2—Disease—PIK3R1—hematologic cancer	2.67e-06	4.74e-05	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—KRAS—hematologic cancer	2.62e-06	4.65e-05	CbGpPWpGaD
Drospirenone—PTGS2—Disease—JAK2—hematologic cancer	2.6e-06	4.61e-05	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—PTEN—hematologic cancer	2.59e-06	4.6e-05	CbGpPWpGaD
Drospirenone—PTGS2—Disease—MDM2—hematologic cancer	2.53e-06	4.5e-05	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—CREBBP—hematologic cancer	2.5e-06	4.44e-05	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—EP300—hematologic cancer	2.47e-06	4.39e-05	CbGpPWpGaD
Drospirenone—PTGS2—Disease—MTOR—hematologic cancer	2.47e-06	4.38e-05	CbGpPWpGaD
Drospirenone—PTGS2—Disease—PIK3CB—hematologic cancer	2.47e-06	4.38e-05	CbGpPWpGaD
Drospirenone—PTGS2—Disease—CD4—hematologic cancer	2.46e-06	4.37e-05	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—PIK3CA—hematologic cancer	2.4e-06	4.27e-05	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—PIK3CD—hematologic cancer	2.37e-06	4.21e-05	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—ALB—hematologic cancer	2.34e-06	4.15e-05	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—TP53—hematologic cancer	2.33e-06	4.13e-05	CbGpPWpGaD
Drospirenone—PTGS2—Disease—CDKN1B—hematologic cancer	2.31e-06	4.11e-05	CbGpPWpGaD
Drospirenone—AR—Gene Expression—AKT1—hematologic cancer	2.3e-06	4.09e-05	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—PIK3R1—hematologic cancer	2.24e-06	3.97e-05	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—HRAS—hematologic cancer	2.22e-06	3.95e-05	CbGpPWpGaD
Drospirenone—PTGS2—Disease—CDKN1A—hematologic cancer	2.14e-06	3.79e-05	CbGpPWpGaD
Drospirenone—PTGS2—Disease—PTEN—hematologic cancer	2.13e-06	3.78e-05	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—IL6—hematologic cancer	2.13e-06	3.78e-05	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—PIK3CB—hematologic cancer	2.07e-06	3.67e-05	CbGpPWpGaD
Drospirenone—PTGS2—Disease—EP300—hematologic cancer	2.03e-06	3.61e-05	CbGpPWpGaD
Drospirenone—PTGS2—Disease—SRC—hematologic cancer	1.98e-06	3.51e-05	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—AKT1—hematologic cancer	1.96e-06	3.49e-05	CbGpPWpGaD
Drospirenone—PTGS2—Disease—STAT3—hematologic cancer	1.91e-06	3.38e-05	CbGpPWpGaD
Drospirenone—PTGS2—Disease—NRAS—hematologic cancer	1.9e-06	3.38e-05	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—PIK3CA—hematologic cancer	1.83e-06	3.25e-05	CbGpPWpGaD
Drospirenone—PTGS2—Disease—MAPK3—hematologic cancer	1.82e-06	3.23e-05	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—PTEN—hematologic cancer	1.78e-06	3.17e-05	CbGpPWpGaD
Drospirenone—PTGS2—Disease—MYC—hematologic cancer	1.77e-06	3.15e-05	CbGpPWpGaD
Drospirenone—PTGS2—Disease—TGFB1—hematologic cancer	1.77e-06	3.14e-05	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—EP300—hematologic cancer	1.7e-06	3.02e-05	CbGpPWpGaD
Drospirenone—PTGS2—Disease—KRAS—hematologic cancer	1.64e-06	2.91e-05	CbGpPWpGaD
Drospirenone—PTGS2—Disease—PIK3CA—hematologic cancer	1.5e-06	2.67e-05	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—AKT1—hematologic cancer	1.49e-06	2.65e-05	CbGpPWpGaD
Drospirenone—PTGS2—Disease—HRAS—hematologic cancer	1.39e-06	2.47e-05	CbGpPWpGaD
Drospirenone—PTGS2—Disease—IL6—hematologic cancer	1.33e-06	2.36e-05	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—PIK3CA—hematologic cancer	1.26e-06	2.24e-05	CbGpPWpGaD
Drospirenone—PTGS2—Disease—AKT1—hematologic cancer	1.23e-06	2.18e-05	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—AKT1—hematologic cancer	1.03e-06	1.83e-05	CbGpPWpGaD
